A Clinical Trial of Anakinra for Steroid-Resistant Autoimmune Inner Ear Disease

Completed · Phase 1/Phase 2

Conditions studied: Sensorineural Hearing Loss, Autoimmune Inner Ear Disease

In brief

The purpose of this study is to determine if Anakinra (an interleukin-1 receptor antagonist) can improve hearing thresholds in those patients with Autoimmune Inner Ear Disease (AIED) that did not respond to oral steroid therapy for a sudden decline in hearing. The patients to be enrolled will have recently completed a course of oral steroids and demonstrated no change in their audiometric thresholds following corticosteroid therapy.

Key facts

Study ID
NCT01267994
Run by
Andrea Vambutas
People needed
13
Starts
2011-06-01
Expected to finish
2014-09-01
Last updated by the study team
2018-01-10

Who can join

Age: 13 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.